India Pharma Outlook Team | Wednesday, 30 July 2025
On July 29, Agilent Technologies, a multinational company that specializes in diagnostics and life sciences, opened its new Biopharma Experience Center in Hyderabad. By providing cutting-edge lab equipment, professional training, and assistance in producing high-quality medications more rapidly and effectively, the institution seeks to boost India's expanding biopharma industry.
Senior executives from the pharmaceutical and biotech sectors, Agilent CEO Padraig McDonnell, and Telangana IT and industries minister D Sridhar Babu attended the center's opening.With end-to-end support that includes chromatography, mass spectrometry, cell analysis, and lab informatics, the facility will concentrate on assisting researchers and businesses in the development of biologics, biosimilars, and precision medicine solutions.
“Hyderabad has emerged as a complete healthcare and life sciences ecosystem—from drug discovery to high-quality patient care,” said Babu. “With top global pharma companies and over 230 USFDA-approved manufacturing units, Telangana is making a strong national and international impact.”
Businesses can test their products for quality and compliance in the new center's real-lab conditions. Additionally, it will offer practical instruction in line with international standards, opening doors for cooperation between businesses, start-ups, and educational institutions.
Also Read: Mass Spectrometry in Biomarker Discovery for Early Disease Detection
“This centre shows our commitment to helping customers bring life-changing therapies to market faster. It also supports the ‘Make-in-India’ initiative by nurturing local innovation, talent, and affordable healthcare solutions,” McDonnel said.
